Kate A. Wyman-Chick, PsyD, ABPP
Clinical Neuropsychologist and Clinician-Investigator at HealthPartners Neuroscience Center
About

Title: Clinical Neuropsychologist and Clinician-Investigator at HealthPartners Neuroscience Center

Education:

  • PsyD, Clinical Psychology, Pacific University
  • Pre-doctoral internship in Clinical Psychology/Neuropsychology, University of Kansas School of Medicine – Wichita
  • Fellowship in Clinical Neuropsychology, University of Virginia
  • Diplomate in Clinical Neuropsychology – American Board of Professional Psychology

Research Interests:

  • Early cognitive changes in Parkinson's disease
  • Early clinical features of dementia with Lewy bodies
  • Reducing hospitalizations/adverse events among patients with dementia with Lewy bodies
  • Neuroimaging correlates of neuropsychological test performance in Parkinson’s disease and dementia with Lewy bodies
  • Cognitive outcomes following neuromodulation in Parkinson’s disease

Dr. Wyman has received special recognition for her research from the International Neuropsychological Society and International Parkinsonism and Movement Disorder Society. Dr. Wyman was honored to receive the 2022 Bronze Level – Rising Star Award at the International Lewy Body Dementia Conference. She has also been recognized for her leadership skills. Dr. Wyman was selected to participate in the 2020 -2021 Movement Disorder Society early-career leadership program, LEAP, and the 2021-2022 early-career leadership program, LEAD, through the National Academy of Neuropsychology. She currently serves on the Publications Committee for the National Academy of Neuropsychology and is an active participant in NIH/NIA study sections through the NIH early-career reviewer program.

Current Research Activities:

  • Principal Investigator on a National Institutes of Health-funded study examining potentially modifiable factors associated with increased health care utilization in patients with dementia with Lewy bodies (NIA/ R21AG074368)
  • Active member of the Lewy Body Dementia Professional Interest Area through the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART)
  • Active member of the Neuropsychology subdivision of the Functional Neurosurgery Working Group through the Parkinson Study Group
Affiliation
positions
  • Investigator and Clinical Neuropsychologist at HealthPartners Neuroscience Center, Neuroscience Research Centers
  • Publications While At HealthPartners
    selected publications
    Journal Article
  • Distinguishing prodromal dementia with Lewy bodies from prodromal Alzheimer disease: a longitudinal study
    Neurology. Clinical practice. 2025
  • Clinical and cognitive features associated with psychosis in Parkinson's disease: a longitudinal study
    Frontiers in Aging Neuroscience. 2024
  • Neuropsychological determinants of impairment in activities of daily living in patients with Lewy body dementia
    Cureus. 2024
  • Low-income older adults' vulnerability to anticholinergic medication-associated frailty
    Drugs and Aging. 2023
  • Assessment of deep brain stimulation candidacy during the COVID-19 pandemic: lessons learned and future directions for neuropsychologists
    Clinical Neuropsychologist. 2022
  • Brief visuospatial memory test-revised normative data and form equivalency for adults ages 80-89
    Clinical Neuropsychologist. 2022
  • Prodromal dementia with Lewy bodies: evolution of symptoms and predictors of dementia onset
    Journal of Geriatric Psychiatry and Neurology. 2022
  • Neuropsychological test performances and depression in early-stage de novo Parkinson's disease
    Archives of Clinical Neuropsychology. 2021
  • Adherence to pharmacotherapy in patients with Parkinson's disease taking three and more daily doses of medication
    Frontiers in Neurology. 2019
  • Frontotemporal lobe degeneration as origin of scans without evidence of dopaminergic deficit
    Frontiers in Neurology. 2018
  • Neuropsychological test performance in Parkinsonism without dopaminergic deficiency on [123I]-FP-CIT SPECT imaging
    Journal of the International Neuropsychological Society. 2018
  • Rates of abnormally low TOPF word reading scores in individuals failing versus passing performance validity testing
    Assessment. 2018
  • Selection of normative group affects rates of mild cognitive impairment in Parkinson's disease
    Movement Disorders. 2018
  • Diagnostic accuracy and confidence in the clinical detection of cognitive impairment in early-stage Parkinson disease
    Journal of Geriatric Psychiatry and Neurology. 2017
  • Contact
    full name
  • Kate A. Wyman-Chick, PsyD, ABPP
  • located in facility
    Quick Info
     
    Collaboration
    More Info